Kadir Çeviker1,2, Şahin Şahinalp3, Erdinç Çiçek4, Deniz Demir5, Dinçer Uysal6, Rasih Yazkan7, Abdullah Akpınar8, Turhan Yavuz6. 1. Departments of Cardiovascular Surgery, Süleyman Demirel University, School of Medicine, Isparta, Turkey. drkadirce@yahoo.com. 2. Kalp Damar Cerrahisi Anabilim Dalı, Tıp Fakültesi, Süleyman Demirel Üniversitesi, Isparta, Turkey. drkadirce@yahoo.com. 3. Departments of Cardiovascular Surgery, Van Training and Research Hospital, Van, Turkey. 4. Departments of Psychiatry, Çumra Government Hospital, Konya, Turkey. 5. Departments of Cardiovascular Surgery, Bursa High Specialty Training and Research Hospital, Bursa, Turkey. 6. Departments of Cardiovascular Surgery, Süleyman Demirel University, School of Medicine, Isparta, Turkey. 7. Departments of Thoracic Surgery, Süleyman Demirel University, School of Medicine, Isparta, Turkey. 8. Departments of Psychiatry, Süleyman Demirel University, School of Medicine, Isparta, Turkey.
Abstract
PURPOSE: The main purpose of this study was to evaluate the influence of any of the four domains of the QoL score in CVD patients of classes C0-C4 and to analyze the correlation between the QoL and types of treatment modalities, and an additional aim of the present study was to compare QoL levels of patients with CVD and healthy participants and was to examine the factors associated with QoL in CVD patients. METHODS: The sample was composed of 501 patients with primary superficial venous reflux (28.5 % male and 71.5 % female) who answered 100 % of the questions in the World Health Organization Quality of Life (WHOQoL-BREF) questionnaire. After a clinical and duplex examination, the patients were categorized as C0-C4, according to the CEAP classification. The relationships between WHOQoL-BREF domains and gender, age, occupation, BMI, the clinical classes of the CEAP classification and four different treatment modalities according to guideline were analyzed. RESULTS: For the WHOQOL-BREF test battery, the patients with CVD had worse values, as compared with the control group participants. The differences were significant for the physical (77.81 ± 12.75 vs. 59.18 ± 12.90, p < 0.001), the psychological (74.78 ± 11.37 vs. 60.21 ± 14.70, p < 0.001), the social relationships (76.56 ± 13.56 vs. 63.07 ± 21.37, p < 0.001) and the environmental (70.27 ± 13.36 vs. 50.16 ± 11.39, p < 0.001) health scores. The patients with CVD had worse WHOQOL-BREF scores at initial, compared with the 6-month follow-up scores. CONCLUSION: This study shows that in spite of undergoing therapy, the subsequent QoL scores did not improve significantly, indicating that CVD continued to negatively affect the patient's life.
PURPOSE: The main purpose of this study was to evaluate the influence of any of the four domains of the QoL score in CVD patients of classes C0-C4 and to analyze the correlation between the QoL and types of treatment modalities, and an additional aim of the present study was to compare QoL levels of patients with CVD and healthy participants and was to examine the factors associated with QoL in CVD patients. METHODS: The sample was composed of 501 patients with primary superficial venous reflux (28.5 % male and 71.5 % female) who answered 100 % of the questions in the World Health Organization Quality of Life (WHOQoL-BREF) questionnaire. After a clinical and duplex examination, the patients were categorized as C0-C4, according to the CEAP classification. The relationships between WHOQoL-BREF domains and gender, age, occupation, BMI, the clinical classes of the CEAP classification and four different treatment modalities according to guideline were analyzed. RESULTS: For the WHOQOL-BREF test battery, the patients with CVD had worse values, as compared with the control group participants. The differences were significant for the physical (77.81 ± 12.75 vs. 59.18 ± 12.90, p < 0.001), the psychological (74.78 ± 11.37 vs. 60.21 ± 14.70, p < 0.001), the social relationships (76.56 ± 13.56 vs. 63.07 ± 21.37, p < 0.001) and the environmental (70.27 ± 13.36 vs. 50.16 ± 11.39, p < 0.001) health scores. The patients with CVD had worse WHOQOL-BREF scores at initial, compared with the 6-month follow-up scores. CONCLUSION: This study shows that in spite of undergoing therapy, the subsequent QoL scores did not improve significantly, indicating that CVD continued to negatively affect the patient's life.
Entities:
Keywords:
Chronic venous disease; Quality of life; Vascular Disease; WHOQOL-BREF
Authors: John J Bergan; Geert W Schmid-Schönbein; Philip D Coleridge Smith; Andrew N Nicolaides; Michel R Boisseau; Bo Eklof Journal: N Engl J Med Date: 2006-08-03 Impact factor: 91.245
Authors: W B Campbell; H Decaluwe; V Boecxstaens; J A MacIntyre; N Walker; J F Thompson; A R Cowan Journal: Eur J Vasc Endovasc Surg Date: 2007-09-17 Impact factor: 7.069
Authors: Peter Gloviczki; Anthony J Comerota; Michael C Dalsing; Bo G Eklof; David L Gillespie; Monika L Gloviczki; Joann M Lohr; Robert B McLafferty; Mark H Meissner; M Hassan Murad; Frank T Padberg; Peter J Pappas; Marc A Passman; Joseph D Raffetto; Michael A Vasquez; Thomas W Wakefield Journal: J Vasc Surg Date: 2011-05 Impact factor: 4.268
Authors: José Aderval Aragão; Rosely Mota Santos; Osmar Max Gonçalves Neves; Iapunira Catarina Sant'Anna Aragão; Felipe Matheus Sant'Anna Aragão; Maria Izabel Aragão Mota; Rebeca de Souza Mariano Bastos; Francisco Prado Reis Journal: J Vasc Bras Date: 2018 Apr-Jun